Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-04-11 00:00:00 ET · period of report 2023-04-06 · accession 0001127602-23-012816 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-11 | 2023-04-06 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | +1,636 | 577.0K | +0.3% | — |
| D | 2023-04-11 | 2023-04-10 | DNA | Dmytruk Mark E. | See remarks | S - Sale+OE | $1.33 | -740 | 576.3K | -0.1% | -$984.20 |
| D | 2023-04-11 | 2023-04-06 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | -1,636 | 648.3K | -0.3% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-04-06 | M | A | 1,636 | — | 576,994 | D | — | — | (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 2 | Common | Class A Common Stock | 2023-04-10 | S | D | 740 | $1.33 | 576,254 | D | — | — | |
| 3 | Derivative | Class B Common Stock | 2023-04-06 | M | D | 1,636 | — | 648,317 | D | — · — to — | 1,636 Class A Common Stock | (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. (F4) Includes shares of Class B Common Stock that are subject to vesting conditions. |